tiprankstipranks
Trending News
More News >
Royalty Pharma PLC (RPRX)
NASDAQ:RPRX
US Market
Advertisement

Royalty Pharma (RPRX) Financial Statements

Compare
1,273 Followers

Royalty Pharma Financial Overview

Royalty Pharma's market cap is currently $21.52B. The company's EPS TTM is $1.141; its P/E ratio is 16.06; and it has a dividend yield of 2.41%. Royalty Pharma is scheduled to report earnings on August 6, 2025, and the estimated EPS forecast is $1.05. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 2.26B$ 2.35B$ 2.24B$ 2.29B$ 2.12B
Gross Profit$ 2.26B$ 2.35B$ 2.24B$ 2.29B$ 0.00
Operating Income$ 1.29B$ 1.49B$ 307.06M$ 1.43B$ 1.60B
EBITDA$ 1.56B$ 1.89B$ 423.69M$ 1.43B$ 1.88B
Net Income$ 858.98M$ 1.13B$ 42.83M$ 619.73M$ 975.04M
Balance Sheet
Cash & Short-Term Investments$ 1.77B$ 1.23B$ 2.43B$ 2.80B$ 2.65B
Total Assets$ 18.22B$ 16.38B$ 16.81B$ 17.52B$ 16.02B
Total Debt$ 7.61B$ 6.14B$ 7.12B$ 7.10B$ 5.82B
Net Debt$ 6.68B$ 5.66B$ 5.41B$ 5.56B$ 4.81B
Total Liabilities$ 7.88B$ 6.30B$ 7.29B$ 7.27B$ 6.12B
Stockholders' Equity$ 6.95B$ 6.53B$ 5.63B$ 5.78B$ 4.82B
Cash Flow
Free Cash Flow$ 2.77B$ 2.99B$ 2.14B$ 2.02B$ 2.03B
Operating Cash Flow$ 2.77B$ 2.99B$ 2.14B$ 2.02B$ 2.03B
Investing Cash Flow$ -2.68B$ -2.07B$ -1.03B$ -1.87B$ -2.76B
Financing Cash Flow$ 361.14M$ -2.15B$ -944.86M$ 385.11M$ 1.49B
Currency in USD

Royalty Pharma Earnings and Revenue History

Royalty Pharma Debt to Assets

Royalty Pharma Cash Flow

Royalty Pharma Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis